HomeCompareKPHWF vs MRK

KPHWF vs MRK: Dividend Comparison 2026

KPHWF yields 3540.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KPHWF wins by $2217404447952.85M in total portfolio value
10 years
KPHWF
KPHWF
● Live price
3540.45%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2217404447952.91M
Annual income
$2,100,685,747,157,062,100.00
Full KPHWF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KPHWF vs MRK

📍 KPHWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKPHWFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KPHWF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KPHWF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KPHWF
Annual income on $10K today (after 15% tax)
$300,938.22/yr
After 10yr DRIP, annual income (after tax)
$1,785,582,885,083,502,800.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KPHWF beats the other by $1,785,582,885,083,494,400.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KPHWF + MRK for your $10,000?

KPHWF: 50%MRK: 50%
100% MRK50/50100% KPHWF
Portfolio after 10yr
$1108702223976.48M
Annual income
$1,050,342,873,578,536,000.00/yr
Blended yield
94.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KPHWF
No analyst data
Altman Z
-40.0
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KPHWF buys
0
MRK buys
0
No recent congressional trades found for KPHWF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKPHWFMRK
Forward yield3540.45%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2217404447952.91M$56.8K
Annual income after 10y$2,100,685,747,157,062,100.00$9,798.13
Total dividends collected$2209400490705.89M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KPHWF vs MRK ($10,000, DRIP)

YearKPHWF PortfolioKPHWF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$364,745$354,044.96$11,206$366.19+$353.5KKPHWF
2$12,459,073$12,068,796.02$12,650$502.35+$12.45MKPHWF
3$398,611,328$385,280,120.14$14,407$694.19+$398.60MKPHWF
4$11,946,626,746$11,520,112,624.20$16,585$967.82+$11946.61MKPHWF
5$335,460,332,442$322,677,441,824.01$19,342$1,363.89+$335460.31MKPHWF
6$8,826,939,751,534$8,467,997,195,821.67$22,913$1,947.19+$8826939.73MKPHWF
7$217,685,670,410,466$208,240,844,876,324.62$27,662$2,823.89+$217685670.38MKPHWF
8$5,032,488,017,138,886$4,799,564,349,799,687.00$34,159$4,173.35+$5032488017.10MKPHWF
9$109,082,897,940,041,140$103,698,135,761,702,530.00$43,337$6,308.80+$109082897940.00MKPHWF
10$2,217,404,447,952,906,200$2,100,685,747,157,062,100.00$56,776$9,798.13+$2217404447952.85MKPHWF

KPHWF vs MRK: Complete Analysis 2026

KPHWFStock

Key Petroleum Limited engages in the acquisition and exploration of petroleum permits in Australia. It primarily holds interests in the ATP 783, 920, and 924 assets in the Cooper Eromanga Basin, Queensland, as well as L7 and EP437 in the Perth Basin, Western Australia. The company was incorporated in 2006 and is based in West Perth, Australia.

Full KPHWF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KPHWF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KPHWF vs SCHDKPHWF vs JEPIKPHWF vs OKPHWF vs KOKPHWF vs MAINKPHWF vs JNJKPHWF vs ABBVKPHWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.